SynAct Pharma AB (OSTO:SYNACT) 50-Day SMA: kr15.45 (As of Jul. 12, 2026)


OSTO:SYNACT SynAct Pharma AB OSTO:SYNACT
18 GF Score
Price kr21.80
! 1 Warning Sign
View Full Analysis

What is SynAct Pharma AB 50-Day SMA?

SynAct Pharma AB OSTO:SYNACT +2.11% 18 50-Day SMA is kr15.45 as of Jul. 12, 2026. GuruFocus rates OSTO:SYNACT with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Moving averages are one of the core indicators in technical analysis. A Simple Moving Average (SMA) is simply the arithmetic average of stock price over a period. It is calculated by adding a selected range of prices, usually closing prices, and then dividing that figure by the number of time periods in that range.

The 50-Day SMA calculates the average price over 50 days. And the 20-Day SMA and 200-Day SMA calculates the average price over 20 days and 200 days separately.

As of today (2026-07-12), SynAct Pharma AB's 50-Day SMA is kr15.45. It's 20-Day SMA is kr16.54 and 200-Day SMA is kr19.23.

SynAct Pharma AB  (OSTO:SYNACT) 50-Day SMA Explanation

Simple Moving Average (SMA) is the arithmetic average of stock price over a period. The 20-Day SMA calculates the average price over 20 days. And the 50-Day SMA and 200-Day SMA calculates the average price over 50 days and 200 days separately. SMAs are often used to determine the price trend direction. A 200-Day SMA is usually a proxy for the long-term trend, while shorter periods indicate short-term trend.

SMA are commonly compared with stock price or different period SMAs to indicate a trading signal. Generally speaking, if the price goes above the SMA, or a short-term SMA crosses above a long-term SMA, an uptrend is expected, investors may want to go long or cover short. Conversely, if the price goes below the SMA, or the short-term SMA crosses below a long-term SMA, a downtrend is expected, investors may want to go short or exit long.

Two popular trading patterns that use SMA include the death cross and a golden cross. A death cross occurs when the 50-day SMA crosses below the 200-day SMA. This is considered a bearish signal, that further losses are in store. The golden cross is a bullish signal which occurs when a short-term SMA crosses above a long-term SMA.

SynAct Pharma AB 50-Day SMA Related Terms

OSTO:SYNACT vs VRTX, REGN, ALNY: 50-Day SMA Comparison

For the Biotechnology subindustry, SynAct Pharma AB's 50-Day SMA, along with its competitors' market caps and 50-Day SMA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SynAct Pharma AB 50-Day SMA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynAct Pharma AB's 50-Day SMA distribution charts can be found below:

* The bar in red indicates where SynAct Pharma AB's 50-Day SMA falls into.


OSTO:SYNACT
18GF Score
SynAct Pharma AB OSTO:SYNACT
50-Day SMA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SynAct Pharma AB  (OSTO:SYNACT) 50-Day SMA Calculation

The formula for calculating SMA is:

SMA=( P1 + P2 + ... + Pn ) / n

where:
Pn is the price of the stock at period n.
n is the total number of periods.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 50-Day SMA →
What does a 50-Day SMA of kr15.45 mean?
SynAct Pharma AB (OSTO:SYNACT) has a 50-Day SMA of kr15.45 as of Jul. 12, 2026. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on SynAct Pharma AB and its competitors.
Is SynAct Pharma AB's 50-Day SMA too high?
SynAct Pharma AB's current 50-Day SMA is kr15.45. Overall, SynAct Pharma AB has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does SynAct Pharma AB's 50-Day SMA compare to VRTX and REGN?
SynAct Pharma AB's 50-Day SMA of kr15.45 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 50-Day SMA for a Biotechnology company?
A good 50-Day SMA depends on the Biotechnology industry context. However, 50-Day SMA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 50-Day SMA mean?
A high 50-Day SMA can signal that a stock is expensive relative to its fundamentals. Simple Moving Average (SMA) is the arithmetic average of stock price over a period. View historical data on SynAct Pharma AB and its competitors. SynAct Pharma AB's current 50-Day SMA is kr15.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SynAct Pharma AB stock overvalued right now?
SynAct Pharma AB (OSTO:SYNACT) has a current 50-Day SMA of kr15.45. The current 50-Day SMA is kr15.45. SynAct Pharma AB's overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 50-Day SMA calculated?
50-Day SMA is calculated from a company's financial statements. For SynAct Pharma AB (OSTO:SYNACT), the current 50-Day SMA is kr15.45 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SynAct Pharma AB Business Description

Other Exchanges 8F8:Germany
Address Scheelevagen 2, Lund, SWE, 223 63
SynAct Pharma AB is a clinical-stage biotechnology company focused on resolving inflammation through the selective activation of the melanocortin system. The company has a broad portfolio of oral and injectable selective melanocortin agonists aimed at inducing anti-inflammatory and inflammation-resolution activity to help patients achieve immune balance and overcome inflammation. AP1189, the company's drug candidate, is being evaluated in three Phase 2 clinical programs regarding rheumatoid arthritis, idiopathic membranous glomerulonephritis and virus-induced respiratory failure.
18GF Score

Get the complete analysis for OSTO:SYNACT

50-Day SMA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr21.80
Price